Finance

Lists
HRTIS:HEL
Herantis Pharma Oyj
1,36 €
+0,89%
(+0,012) 1D
14-окт., 15:02:21 GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HRTIS...
Open
1,36 €
High
1,37 €
Low
1,34 €
Mkt. cap
36,05 млн
Avg. vol.
24,79 миң
Volume
7,99 миң
52-wk high
2,87 €
52-wk low
1,32 €
EPS
-0,28 €
Shares outstanding
26,50 млн
No. of employees
14
Open
1,36 €
High
1,37 €
Low
1,34 €
Mkt. cap
36,05 млн
Avg. vol.
24,79 миң
Volume
7,99 миң
52-wk high
2,87 €
52-wk low
1,32 €
EPS
-0,28 €
Shares outstanding
26,50 млн
No. of employees
14
News stories
From web sources and news partners
About Herantis Pharma Oyj
CEOAntti Vuolanto
Employees14
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,99 миң
402,99 миң
585,00 миң
585,00 миң
Operating expense
1,72 млн
1,72 млн
1,53 млн
1,53 млн
Total operating expenses
1,72 млн
1,72 млн
1,53 млн
1,53 млн
Operating income
-1,72 млн
-1,72 млн
-1,53 млн
-1,53 млн
Other non operating income
-150,07 миң
-150,07 миң
15,00 миң
15,00 миң
EBT including unusual items
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
EBT excluding unusual items
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
1,32 млн
1,32 млн
946,50 миң
946,50 миң
Net income
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
160,84 миң
160,84 миң
3,50 миң
3,50 миң
Interest expense
-
-
-149,00 миң
-149,00 миң
Net interest expenses
160,84 миң
160,84 миң
-145,50 миң
-145,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору